SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19687728
Source:
http://linkedlifedata.com/resource/pubmed/id/19687728
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0205179
,
umls-concept:C0205210
,
umls-concept:C0238462
,
umls-concept:C0388638
,
umls-concept:C0450442
,
umls-concept:C0684224
,
umls-concept:C0814225
pubmed:issue
2
pubmed:dateCreated
2010-4-8
pubmed:abstractText
To assess clinical benefit of plitidepsin (Aplidine) in patients with advanced medullary thyroid carcinoma (MTC).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8207754
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Depsipeptides
,
http://linkedlifedata.com/resource/pubmed/chemical/Marine Toxins
,
http://linkedlifedata.com/resource/pubmed/chemical/aplidine
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1537-453X
pubmed:author
pubmed-author:CiruelosEvaE
,
pubmed-author:DomínguezMaría JMJ
,
pubmed-author:FaivreSandrineS
,
pubmed-author:IzquierdoMiguel AMA
,
pubmed-author:JimenoJoséJ
,
pubmed-author:López-MartínJosé AJA
,
pubmed-author:Le TourneauChristopheC
,
pubmed-author:RaymondEricE
pubmed:issnType
Electronic
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
132-6
pubmed:meshHeading
pubmed-meshheading:19687728-Adult
,
pubmed-meshheading:19687728-Aged
,
pubmed-meshheading:19687728-Antineoplastic Agents
,
pubmed-meshheading:19687728-Bone Neoplasms
,
pubmed-meshheading:19687728-Carcinoma, Medullary
,
pubmed-meshheading:19687728-Depsipeptides
,
pubmed-meshheading:19687728-Female
,
pubmed-meshheading:19687728-Follow-Up Studies
,
pubmed-meshheading:19687728-Humans
,
pubmed-meshheading:19687728-Liver Neoplasms
,
pubmed-meshheading:19687728-Lung Neoplasms
,
pubmed-meshheading:19687728-Male
,
pubmed-meshheading:19687728-Marine Toxins
,
pubmed-meshheading:19687728-Maximum Tolerated Dose
,
pubmed-meshheading:19687728-Middle Aged
,
pubmed-meshheading:19687728-Survival Rate
,
pubmed-meshheading:19687728-Thyroid Neoplasms
,
pubmed-meshheading:19687728-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma.
pubmed:affiliation
Department of Medical Oncology, Beaujon University Hospital, Clichy, France. christophe.letourneau@uhn.on.ca
pubmed:publicationType
Journal Article
,
Clinical Trial, Phase I